Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Introduction to Fibroblasts01:09

Introduction to Fibroblasts

Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Functional, molecular, and digital measurements of biological age.

The Journal of clinical investigation·2026
Same author

A tribute to Eugene Braunwald (1929-2026).

The Journal of clinical investigation·2026
Same author

Erythroid-produced intact FGF23 is a paracrine inhibitor of erythropoiesis.

Blood·2026
Same author

Metabolic Vulnerability Index and Risk of Total Mortality: Findings From the Multi-Ethnic Study of Atherosclerosis.

Circulation. Population health and outcomes·2026
Same author

Plasminogen activator inhibitor 1 promotes aortic aging-like pathophysiology in humans and mice.

The Journal of clinical investigation·2025
Same author

Excess of rare noncoding variants in several type 2 diabetes candidate genes among Asian Indian families.

Communications medicine·2025

Related Experiment Video

Updated: Jun 3, 2026

Ex Vivo Corneal Organ Culture Model for Wound Healing Studies
06:46

Ex Vivo Corneal Organ Culture Model for Wound Healing Studies

Published on: February 15, 2019

PAI-1 in tissue fibrosis.

Asish K Ghosh1, Douglas E Vaughan

  • 1Feinberg Cardiovascular Research Institute, Feinberg School of Medicine, Northwestern University, Chicago, Illinois 60611, USA. a-ghosh2@northwestern.edu

Journal of Cellular Physiology
|April 6, 2011
PubMed
Summary

Plasminogen activator inhibitor-1 (PAI-1) is crucial in fibrosis, regulating extracellular matrix degradation. While essential for wound healing, excessive PAI-1 drives pathological scarring and organ fibrosis.

Area of Science:

  • Fibrosis research
  • Cellular biology
  • Extracellular matrix dynamics

Background:

  • Fibrosis involves abnormal fibroblast activation and excessive extracellular matrix (ECM) accumulation.
  • ECM degradation is regulated by plasminogen activator system (uPA/tPA/plasmin) and matrix metalloproteinases (MMPs).
  • Plasminogen activator inhibitor-1 (PAI-1) is a key regulator of these proteolytic activities.

Purpose of the Study:

  • To review the multifaceted role of PAI-1 in the pathogenesis of fibrosis across multiple organs.
  • To elucidate how PAI-1 levels influence ECM deposition and tissue homeostasis.
  • To highlight the paradoxical effects of PAI-1 in different fibrotic conditions.

Main Methods:

  • Literature review of studies investigating PAI-1 and fibrosis.

Related Experiment Videos

Last Updated: Jun 3, 2026

Ex Vivo Corneal Organ Culture Model for Wound Healing Studies
06:46

Ex Vivo Corneal Organ Culture Model for Wound Healing Studies

Published on: February 15, 2019

  • Analysis of the regulatory mechanisms of PAI-1 in ECM remodeling.
  • Examination of PAI-1's involvement in organ-specific fibrotic diseases.
  • Main Results:

    • Elevated PAI-1 levels are associated with excessive collagen accumulation and pathological scarring.
    • PAI-1 inhibition of uPA/tPA/plasmin/MMP pathways contributes to fibrosis.
    • Lack of PAI-1 generally protects against fibrosis, but paradoxical cardiac-selective fibrosis occurs in PAI-1 deficient models.

    Conclusions:

    • PAI-1 plays a significant, often detrimental, role in the pathology of fibrosis in organs like the heart, lung, kidney, liver, and skin.
    • Understanding PAI-1's dual role is critical for developing targeted anti-fibrotic therapies.
    • Further research is needed to clarify the paradoxical PAI-1 deficiency-induced cardiac fibrosis.